May 2005
Volume 46, Issue 13
Free
ARVO Annual Meeting Abstract  |   May 2005
A Comparison of VigamoxTM and ZymarTM Treatment on Corneal Wound Healing in Pigmented Rabbits following Anterior Keratectomy
Author Affiliations & Notes
  • J.M. Griffin
    Alcon Research, Ltd., Ft. Worth, TX
  • K.K. Williams
    Alcon Research, Ltd., Ft. Worth, TX
  • R.L. Rice
    Alcon Research, Ltd., Ft. Worth, TX
  • M.D. McCartney
    Alcon Research, Ltd., Ft. Worth, TX
  • O. Dembinska
    Alcon Research, Ltd., Ft. Worth, TX
  • M. Brady
    Alcon Research, Ltd., Ft. Worth, TX
  • D.B. Cantu–Crouch
    Alcon Research, Ltd., Ft. Worth, TX
  • P.G. Neill
    Alcon Research, Ltd., Ft. Worth, TX
  • R.B. Hackett
    Alcon Research, Ltd., Ft. Worth, TX
  • J.W. Hiddemen
    Alcon Research, Ltd., Ft. Worth, TX
  • Footnotes
    Commercial Relationships  J.M. Griffin, Alcon Research, Ltd. E; K.K. Williams, Alcon Research, Ltd. E; R.L. Rice, Alcon Research, Ltd. E; M.D. McCartney, Alcon Research, Ltd. E; O. Dembinska, Alcon Research, Ltd. E; M. Brady, Alcon Research, Ltd. E; D.B. Cantu–Crouch, Alcon Research, Ltd. E; P.G. Neill, Alcon Research, Ltd. E; R.B. Hackett, Alcon Research, Ltd. E; J.W. Hiddemen, Alcon Research, Ltd. E.
  • Footnotes
    Support  None.
Investigative Ophthalmology & Visual Science May 2005, Vol.46, 4904. doi:
  • Views
  • Share
  • Tools
    • Alerts
      ×
      This feature is available to authenticated users only.
      Sign In or Create an Account ×
    • Get Citation

      J.M. Griffin, K.K. Williams, R.L. Rice, M.D. McCartney, O. Dembinska, M. Brady, D.B. Cantu–Crouch, P.G. Neill, R.B. Hackett, J.W. Hiddemen; A Comparison of VigamoxTM and ZymarTM Treatment on Corneal Wound Healing in Pigmented Rabbits following Anterior Keratectomy . Invest. Ophthalmol. Vis. Sci. 2005;46(13):4904.

      Download citation file:


      © ARVO (1962-2015); The Authors (2016-present)

      ×
  • Supplements
Abstract

Abstract: : Purpose: These experiments were conducted in pigmented rabbits to measure healing rates and type IV collagen expression in corneas treated with either moxifloxacin 0.5% ophthalmic solution (VigamoxTM) or gatifloxacin 0.3% ophthalmic solution (ZymarTM) following anterior keratectomy. Methods: An 8.5 mm central anterior keratectomy was created in the right eye of each animal using a microkeratome. Rabbits (n = 10/group) were dosed with one drop, TID for 4 days with VigamoxTM, ZymarTM, or BSS® sterile irrigating solution. Fluorescein images were obtained daily and analyzed for changes in wound area. At approximately 48 or 96 hours following surgery ( n = 5/group/time point), aqueous humor samples were collected and analyzed for the inflammatory mediators PGE2 and IL–1ß. Corneas were then collected and evaluated using both scanning and transmission electron microscopy. A second parallel study was conducted following the methods described above in which the eyes were evaluated for type IV collagen and ZO–1 using immunohistochemistry. Results: Fluorescein images revealed 90% ± 8% healing for Vigamox at 96 hours compared with 81% ± 14% for Zymar (P > 0.05). Similar aqueous humor levels of PGE2 were observed in all groups, while IL–1ß was undetectable. There was no significant difference between Vigamox, Zymar and BSS for type IV collagen or ZO–1 expression at 48 or 96 hours and there was no difference between the groups with regards to morphological appearance as demonstrated with electron microscopy. Zymar showed a non–significant trend towards a slower rate of re–epithelialization of the corneal wound in both studies. Conclusions: Following anterior keratectomy, aqueous humor concentrations of PGE2 and IL–1ß of Vigamox or Zymar treated eyes were equivalent to the BSS® control. Corneal re–epithelializaton rates and levels of type IV collagen and ZO–1 were similar with Vigamox or Zymar treatment after surgery.

Keywords: antibiotics/antifungals/antiparasitics • wound healing • cornea: epithelium 
×
×

This PDF is available to Subscribers Only

Sign in or purchase a subscription to access this content. ×

You must be signed into an individual account to use this feature.

×